Status:
NOT_YET_RECRUITING
Black Seed Oil in ADHD
Lead Sponsor:
Ain Shams University
Conditions:
ADHD
Eligibility:
All Genders
6-12 years
Phase:
PHASE2
Brief Summary
Attention-Deficit/Hyperactivity Disorder is one of the most prevalent neuropsychiatric disorders affecting children with known persistence into adulthood in about 60% of patients. The mainstay treatme...
Detailed Description
Attention-Deficit/Hyperactivity Disorder (ADHD) is a childhood-onset neurodevelopmental disorder characterized by age-inappropriate levels of inattention and hyperactivity/impulsivity symptoms that in...
Eligibility Criteria
Inclusion
- Children aged 6 to 12 years old who can swallow capsules.
- Diagnosed with ADHD according to the DSM-V criteria
- Having a stable dose of atomoxetine for at least 12 weeks prior to the study.
Exclusion
- If there is any alteration in the ADHD treatment plan or being incompliant.
- Having any other psychiatric or neurological disorder that may interfere with the study outcomes like Autism, Anxiety, Obsessive compulsive disorder.
- Having any known allergy or hypersensitivity to black seed oil or its components.
- Having bleeding disorders or taking blood thinners.
- Having diabetes or taking medications that affect blood sugar levels.
- Having renal or hepatic impairment
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06542887
Start Date
October 1 2024
End Date
October 1 2025
Last Update
August 9 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.